|
|
|
Volumn 1, Issue 5, 1997, Pages 366-378
|
|
Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small- cell lung cancer after complete resection
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BUSULFAN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
HYDROXYUREA;
LOMUSTINE;
METHOTREXATE;
TEGAFUR;
UFT;
VINBLASTINE;
VINCRISTINE;
VINDESINE;
CANCER ADJUVANT THERAPY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED STUDY;
EVIDENCE BASED MEDICINE;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
CARCINOMA, NON-SMALL-CELL LUNG;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
HUMANS;
LUNG NEOPLASMS;
NEOPLASM STAGING;
RADIOTHERAPY, ADJUVANT;
|
|
EID: 0031411337
PISSN: 1206548X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (26)
|
|
References (27)
|
